Carbidopa And Levodopa Tablet
Product Images NDC 72865-362

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Carbidopa And Levodopa (NDC 72865-362). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xlcare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10-100mg-1000s Count (10 100mg 1000s)

This is a description for Carbidopa and Levodopa Tablets, USP by XLcare Pharmaceuticals Inc. Each tablet contains 10 mg carbidopa and 100 mg levodopa. It is recommended to store the tablets at 20° to 25°C. The usual adult dosage can be found in the package insert. The tablets should be dispensed in a tightly closed, light-resistant container. The package is not child resistant and is intended for bulk dispensing. Manufactured by Ascent Pharmaceuticals, Inc., and distributed by XLCare Pharmaceuticals, Inc.*

FDA Label Image

10-100mg-100s Count (10 100mg 100s)

This is a description of Carbidopa and Levodopa Tablets, USP containing 10 mg of carbidopa and 100 mg of levodopa per tablet. They are to be stored at 20°to 25°C (68°to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F). The manufacturer is Ascent Pharmaceuticals, Inc., based in Central Islip, NY, and the tablets are distributed by XLCere Pharmaceuticals, Inc. located in Lawrenceville, GA. The usual adult dosage details can be found in the package insert.*

FDA Label Image

25-100mg-1000s Count (25 100mg 1000s)

This is a medication consisting of 25 mg of carbidopa and 100 mg of levodopa per tablet. It is used to treat certain conditions. The tablets should be stored at 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). They should be kept in a tightly closed container away from light and moisture. This product is for adult use only. The tablets are light-resistant and should not be dispensed to children. The medication is manufactured by Ascent Pharmaceuticals, Inc. for XLCare Pharmaceuticals, Inc. It comes in a bulk package containing 1000 tablets.*

FDA Label Image

25-100mg-100s Count (25 100mg 100s)

This is the product label for XLcare NDC 72865-362-01 Carbidopa and Levodopa Tablets, USP 25 mg/100 mg. Each tablet contains 25 mg carbidopa and 100 mg levodopa. It is recommended to store the tablets at 20° to 25°C (68 to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F). Usual adult dosage information can be found in the package insert. The tablets should be dispensed in a tightly closed, light-resistant container. Produced by Ascent Pharmaceuticals, Inc., and distributed by XLCare Pharmaceuticals, Inc.*

FDA Label Image

25-250mg-1000s Count (25 250mg 1000s)

This text provides information on a medication composed of 25mg Carbidopa, USP and 250mg Levodopa, USP in tablet form. It also includes storage instructions, dosage guidelines, manufacturer details (Ascent Pharmaceuticals, Inc.), as well as a note that the package is not child-resistant. The text mentions a bulk package intended for dispensing purposes, not for individual sale, with the address of the manufacturer included.*

FDA Label Image

25-250mg-100s Count (25 250mg 100s)

This text is a product label for Carbidopa and Levodopa Tablets, USP of strength 25 mg/250 mg. It includes information on usage instructions, storage conditions, dosage recommendations, manufacturer details, and where the product is manufactured for.*

FDA Label Image

Carbidopa Structure (Carbidopa Structure)

FDA Label Image

Levodopa Structure (Levodopa Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.